BSECompany UpdateResults11 Aug 2026
Laxmi Dental Ltd
Allotment of 59,360 Equity Shares of face value of INR. 2 each under Laxmi Dental Stock Options Scheme 2024.
Laxmi Dental Ltd has announced the allotment of 59,360 equity shares to eligible employees under the Laxmi Dental Stock Options Scheme 2024. The company has also approved the acquisition of land for INR 6,21,00,000 and disclosed unaudited financial results for Q1 FY26-27.
BSEResultResults11 Aug 2026
Laxmi Dental Ltd
Declaration of Unaudited Financial Results for the quarter ended June 30, 2026.
Laxmi Dental Ltd has declared unaudited financial results for Q1 FY27, approved the acquisition of land for expansion, and allotted 59,360 equity shares to employees under the ESOP 2024 scheme. The company also noted the surrender of employee stock options by Mr. Ansari Mohammed Saad.
BSEBoard MeetingExpansion11 Aug 2026
Laxmi Dental Ltd
Outcome of Board Meeting of Laxmi Dental Limited held on Tuesday, August 11, 2026 for approval of un-audited financial results (standalone and consolidated) for the quarter ended June 30, ....
Laxmi Dental Ltd's board meeting outcome: approved acquisition of land for expansion, allotment of 59,360 equity shares to employees, and unaudited financial results for Q1 FY26-27.
BSECompany UpdateResults7 Aug 2026
Laxmi Dental Ltd
Pursuant to the Regulation 30(6), read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, this is to ....
Laxmi Dental Ltd has scheduled a Q1FY27 earnings conference call on August 12, 2026, to discuss unaudited financial results for the quarter ended June 30, 2026.
BSEBoard MeetingResults7 Aug 2026
Laxmi Dental Ltd
Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Laxmi Dental Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.